ARCHIVES

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976

ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting

January 9, 1976